Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisPatricia Cortazar, Gϋnter von Minckwitz, Hervé Bonnefoi et al.|The Lancet|2014Cited by 4.7k
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsRobert E. Coleman, Nigel Bundred, Richard de Boer et al.|Annals of Oncology|2012Cited by 337
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST StudyHolger Eidtmann, Robert E. Coleman, Richard de Boer et al.|Annals of Oncology|2010Cited by 280